Ireland
--:--IST
Latest
Clinical Trials in Portugal / NCT07567820
Starting soon Not applicable

Feasibility and Preliminary Outcomes of the Brave Elephant Program: A Single-Arm Pretest-Posttest Study

NCT07567820 · tracked via the Priya Life Science Portugal tracker
Phase
Not applicable
Started
2026-09
Last updated
2026-05-08

Condition(s) studied

Anxiety

Investigational drug(s) / intervention(s)

Brave Elephant Program

Brave Elephant Program: The Brave Elephant Program is implemented across three parallel components. The professional component is delivered by two trained psychologists through psychoeducational workshops and individualized classroom coaching sessions. This component focuses on understanding behavioral inhibition, promoting positive relationships, emotional regulation, social engagement and social problem-solving. The child component is delivered by early education professionals in the classroom through age-appropriate didactic activities (e.g., modeling/role-play, mindfulness activities, and supervised free play with adults and peers to enhance socioemotional competence. The family component is also delivered by early education professionals, by sharing the materials and activities that are implemented in the classroom with parents to promote skill generalization across contexts.

Study summary

Anxiety disorders are highly prevalent in childhood and have increased following the COVID-19 pandemic. Behavioral inhibition in early childhood is a well-established risk factor for later anxiety. School-based preventive interventions that target both classroom environments and individual child characteristics may help reduce early risk and improve socioemotional development. Interventions delivered in preschool settings that address the needs of behaviorally inhibited children, while also supporting professional development, may improve the quality of interactions within the classroom and with families, and promote positive developmental outcomes.

The Brave Elephant Program is an evidence-based intervention grounded in a bioecological developmental framework. It aims to empower early childhood education professionals to promote socioemotional competence and resilience in all children, while addressing the specific needs of behaviorally inhibited preschoolers and enhancing educators' professional development. This study will evaluate the feasibility, acceptability, and preliminary outcomes of the program using a single-arm pretest-posttest design.

Eligibility

Sex
ALL
Min age
3 Years
Max age
6 Years
Healthy volunteers
Accepted
Inclusion criteria: * Children's age between 3 and 6 years * Parents' written informed consent for children's participation in the study. * Children's informed assent to participate in the study. * Parents' ability to read and understand Portuguese. * Early childhood and care professionals' ability to read and understand Portuguese * Early childhood and care professionals' full-time contract for the school year. Exclusion criteria: * Children's developmental disorders * Children's, parents' and early education professionals' are enrolled in another psychological intervention.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ispa - Instituto Universitário Lisbon Portugal

More ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida trials in Portugal

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07567820 on ClinicalTrials.gov ↗ ← All trials in Portugal